Patients undergoing dual antiplatelet therapy are in this group. Platelets provide the initial hemostatic plug at the site of vascular injury and are involved in atherosclerotic processes.

The appropriate duration of dual antiplatelet therapy in patients at high risk for bleeding after the implantation of a drug-eluting coronary stent remains unclear. One month after they had ...

WASHINGTON, DC—Compared with dual antiplatelet therapy (DAPT), taking a single antiplatelet following TAVI is associated with a lower rate of all-cause mortality and major bleeding at 6 months, ...

Certain invasive procedures carry a degree of bleeding risk that is increased in the presence of antithrombotic therapy. The need to withhold antiplatelet therapy depends on the risks of bleeding ...

Single antiplatelet therapy was tied to lower 6-month mortality risk vs. dual antiplatelet therapy after transcatheter aortic valve replacement. The results were consistent by sex and presence of CAD.

Apixaban, an oral, direct factor Xa inhibitor, may reduce the risk of recurrent ischemic events when added to antiplatelet therapy after an acute coronary syndrome. The trial was terminated ...

Less attention has been paid to the confounding role that patient nonadherence has on individual response to antiplatelet therapy, but accruing evidence indicates that nonadherence has a dominant ...

New data from an observational study provide some support for antiplatelet therapy in patients with moyamoya disease, a rare arteriopathy characterized by progressive stenosis of the distal internal ...

Share on Pinterest New research suggests that antiplatelet therapy and anticoagulants may help treat people with long COVID. Tara Moore/Getty Images Scientists know little about the underlying ...

Dual antiplatelet therapy for 1 month was inferior to 3 months for patients with high bleeding risk after PCI. DAPT for 3 months was superior to 12 months for patients with low bleeding risk.

While routine treatment with aspirin plus a second anti-clotting drug, known as dual antiplatelet therapy (DAPT), can prevent blood clots, these drugs may increase risk for bleeding, especially ...